• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A Framework for Applying Health Technology Assessment in Cyprus: Thoughts, Success Stories, and Recommendations.

作者信息

Petrou Panagiotis, Talias Michalis A

机构信息

Healthcare Management Programme, Open University of Cyprus, Nicosia, Cyprus.

Healthcare Management Programme, Open University of Cyprus, Nicosia, Cyprus.

出版信息

Value Health Reg Issues. 2013 Sep-Oct;2(2):273-278. doi: 10.1016/j.vhri.2013.06.016. Epub 2013 Sep 13.

DOI:10.1016/j.vhri.2013.06.016
PMID:29702877
Abstract

OBJECTIVES

Health care decision making, assessment, and procurement of medicines is a complex, human resource-demanding, and time-consuming process. A thorough evaluation of all factors involved is necessary to optimize the process. The objective of this study was to describe and analyze the current stage of health technology assessment (HTA) in Cyprus.

METHODS

Literature research and private communication with all involved parties and competent authority. Moreover, data, decisions, and recommendations of the Drug's Committee were used.

RESULTS

Cyprus is a latecomer in this field. HTA has entered a growing phase after the 2007 reform. It has not reached its full potential, and the current state is applicable only to the public sector, because of the nonexistence of a national health system. Therefore, this poses both a great challenge and a great barrier considering maximization of the value of money spent and health access equity.

CONCLUSIONS

There is definitely enough space and clear necessity for further dissemination, and early successes indicate that steps should be taken toward the introduction of an HTA procedure that will cover both private and public sectors. The introduction of a national health system will further enhance the uptake of HTA, optimize the process, and use the common knowledge strategy for evidence-based decision making.

摘要

相似文献

1
A Framework for Applying Health Technology Assessment in Cyprus: Thoughts, Success Stories, and Recommendations.
Value Health Reg Issues. 2013 Sep-Oct;2(2):273-278. doi: 10.1016/j.vhri.2013.06.016. Epub 2013 Sep 13.
2
Health technology assessment of medical devices: What is different? An overview of three European projects.医疗设备的卫生技术评估:有何不同?三个欧洲项目概述。
Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):309-18. doi: 10.1016/j.zefq.2015.06.011. Epub 2015 Jul 26.
3
Community views and perspectives on public engagement in health technology assessment decision making.社区对公众参与卫生技术评估决策的看法和观点。
Aust Health Rev. 2017 Mar;41(1):68-74. doi: 10.1071/AH15221.
4
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
5
Development and implementation of health technology assessment in Argentina: two steps forward and one step back.阿根廷卫生技术评估的发展与实施:前进两步,后退一步。
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:260-9. doi: 10.1017/S0266462309090734. Epub 2009 Jun 16.
6
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
7
Austria: history of health technology assessment during the past 20 years.奥地利:过去20年的卫生技术评估历史
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:74-81. doi: 10.1017/S026646230909045X. Epub 2009 Jun 8.
8
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
9
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
10
The impact of health technology assessment reports on decision making in Austria.卫生技术评估报告对奥地利决策的影响。
Int J Technol Assess Health Care. 2012 Jan;28(1):77-84. doi: 10.1017/S0266462311000729. Epub 2012 Jan 11.

引用本文的文献

1
Seeking to introduce a pharmacoeconomics framework in Cyprus.寻求在塞浦路斯引入药物经济学框架。
Int J Public Health. 2019 Apr;64(3):309-310. doi: 10.1007/s00038-018-1161-z. Epub 2018 Oct 3.
2
A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.一项通过药物经济学建模评估塞浦路斯基于价值的定价可行性的初步研究,并评估其运营框架:索拉非尼二线治疗肾细胞癌。
Cost Eff Resour Alloc. 2014 May 3;12:12. doi: 10.1186/1478-7547-12-12. eCollection 2014.